UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Section 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of March 2020
Commission File Number: 001-39034
BELLUS HEALTH INC.
(Name of registrant)
275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F [ ] Form 40-F [ X ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: March 11, 2020 | BELLUS Health Inc.. | |
By: | /s/ François Desjardins | |
Name: | François Desjardins | |
Title: | Vice President, Finance |
Exhibit | DESCRIPTION |
99.1 | Notice of the Meeting and Record Date |
1500 Robert-Bourassa Blvd. | |
Date: March 11, 2020 | 7th Floor |
Montreal QC, H3A 3S8 | |
www.computershare.com |
To: | All Canadian Securities Regulatory Authorities |
Subject: BELLUS HEALTH INC.
Dear Sir/Madam:
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
Meeting Type : | Annual General and Special Meeting |
Record Date for Notice of Meeting : | March 27, 2020 |
Record Date for Voting (if applicable) : | March 27, 2020 |
Beneficial Ownership Determination Date : | March 27, 2020 |
Meeting Date : | May 14, 2020 |
Meeting Location (if available) : | Laval, QC |
Issuer sending proxy related materials directly to NOBO: | Yes |
Issuer paying for delivery to OBO: | Yes |
Notice and Access (NAA) Requirements: | |
NAA for Beneficial Holders |
No |
NAA for Registered Holders |
No |
Voting Security Details: | ||
Description | CUSIP Number | ISIN |
COMMON SHARES | 07987C204 | CA07987C2040 |
Sincerely,
Computershare
Agent for BELLUS HEALTH INC.
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end